Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06332014 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China

StatusActive, Not Recruiting
PhasePhase 4
SponsorAmgen
Started2024-08-06
View on ClinicalTrials.gov ↗
The primary objective of this study is to evaluate the efficacy of Prolia on lumbar spine BMD at 12 months.

Amendment record

Amended 11 times since 2024-03-19; most recent filed 2026-02-10. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2026-02-10
Amendment Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v11
2025-10-14
Amendment Study Status v10
2025-09-02
Amendment Study Status v9
2025-07-02
Amendment Study Status, Contacts/Locations v8
2025-06-25
Amendment Study Status, Contacts/Locations v7
2025-06-18
Amendment Study Status, Contacts/Locations v6
2025-06-11
Amendment Study Status, Contacts/Locations v5
2025-05-21
Amendment Study Status, Eligibility v4
2025-03-12
Amendment Study Status, Contacts/Locations v3
2024-10-09
Amendment Study Status v2
2024-08-30
Amendment Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
2024-03-19
Original filing
Trial Details
NCT Number NCT06332014
Lead Sponsor Amgen
Conditions Osteoporosis
Enrollment 102 participants
Start Date 2024-08-06
Primary Completion 2027-01-23 (estimated)
Study Completion 2027-01-23 (estimated)
Updated on ClinicalTrials.gov 2026-02-12